OSTEOPOROSIS AND BREAST CANCER RESEARCH CENTER (EIN 330950811) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2000

Legal Domicile

Principal Officer

PAMELA HOUGHTEN

Phone

7723454800

Tax Period

2020-07-01 to 2021-03-31

OSTEOPOROSIS AND BREAST CANCER RESEARCH CENTER, founded in 2000, is a micro nonprofit that reported $2K in total revenue in fiscal year 2020. Revenue fell 94% from the prior year — a significant decline worth monitoring. Expenses of $20K exceeded revenue, resulting in a 1009% operating deficit.

Mission

OSTEOPOROSIS & BREAST CANCER RESEARCH CENTER (OBCRC) IS DEDICATED TO SUPPORT RESEARCH DIRECTED TOWARDS THE DISCOVERY AND DEVELOPMENT OF INNOVATIVE METHODS TO TREAT AND POSSIBLY CURE OSTEOPOROSIS, BREAST CANCER, AND THE MYRIAD OF

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2020)

Revenue Breakdown

Contributions & Grants $1,821

Program Service Revenue $0

Investment Income $5

Other Revenue $0

TOTAL REVENUE $1,826

Expense Breakdown

Grants Paid $10,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $19,122

Other Expenses $10,250

TOTAL EXPENSES $20,250

Year-over-Year Comparison

	2020	2019	Change
Revenue	$1,826	$29,088	-0.9%
Expenses	$20,250	$75,861	-0.7%
Net Income	$-18,424	$-46,773	-0.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$12,691

Total Directors

$12,691

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PAMELA HOUGHTEN	SECRETARY/TRUSTEE	1.00	Officer Director	$0	$0	$12,691
ROBERT S HODGES	TRUSTEE	1.00	Director	$0	$0	$0
ANDREA RESNICK	TRUSTEE	1.00	Director	$0	$0	$0
PATRICIA S WU	TRUSTEE	1.00	Director	$0	$0	$0
GEORGE B THORNTON	PRESIDENT/TRUSTEE	1.00	Officer Director	$0	$0	$0
RICHARD HOUGHTEN	PRESIDENT	1.00	Officer Director	$0	$0	$0
TOBIN TOBY OVERDORF	TRUSTEE	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2021	$1,826	$20,250	No data	$-18,424
2020	$29,088	$75,861	$24,468	$-46,773
2019	$15,301	$27,618	$83,297	$-12,317
2018	$46,167	$203,670	$91,929	$-157,503

OSTEOPOROSIS AND BREAST CANCER RESEARCH CENTER